Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,472.40
(
-2.09%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
6.18%
)
Bitcoin
66,015.03
(
-4.03%
)
News Focus
News Focus
Post# of 257297
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122815
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 165404

Monday, 11/21/2016 10:26:52 AM

Monday, November 21, 2016 10:26:52 AM

Post# of 257297
GSK submits NDA/MAA for triple-MoA* COPD regimen:

http://www.pmlive.com/pharma_news/gsk_files_first_application_for_triple_copd_therapy_1177783

Each component of this three-drug regimen is already on the market as monotherapy or as a component of a dual-MoA combination.

*LABA/LAMA/ICS.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today